FindTrial
Sign In

To study the role of low dose Aspirin in prevention of Preeclampsia

Low Dose Aspirin in Prevention of Preeclampsia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/05/019232
Enrollment
110
Registered
2019-05-20
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O149- Unspecified pre-eclampsia

Interventions

Intervention1: Low Dose Aspirin in prevention of Preeclampsia: Open label randomized controlled trial of 110 samples will be conducted in a tertiary Center (department of O&G VIMSAR, Burla) .Aspirin(

Sponsors

Vss Institute of medical science and research
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Pregnant lady( aged 18- 55 years) in 1st trimester between (11th- 14th) wks of gestation with high risk of developing Preeclampsia: . Women with H/O Preeclampsia. . Women with chronic hypertension, renal disease . Obesity:BMI >35kg/m², Insulin resistance . Pregestational diabetes . Autoimmune disease . Hyperplacentosis:Molar pregnancy, multifetal gestation . Able to provide written. Informed consent.

Exclusion criteria

Exclusion criteria: . Allergy to salicylates . Low cardiac reserve, CHF . Acid peptic disease . Asthma . Bleeding diathesis

Design outcomes

Primary

MeasureTime frame
Aspirin in low dose may be effective in prevention of Preeclampsia and improve feto- maternal outcomesTimepoint: Number of women developing Preeclampsia after 20 wks of gestation—

Secondary

MeasureTime frame
Low dose aspirin may improve fetal outcomeTimepoint: Number of still birth, preterm birth, neonatal death, NICU admission, fetal growth retardation after delivery—

Countries

India

Contacts

Public ContactDr Roshan meher

Vss Institute of medical science and research

drmamatasoren@gmail.com7381830777

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026